An FDA advisory committee voted unanimously to recommend Moderna’s new mRNA flu vaccine for older adults, potentially transforming influenza prevention.
Tag: Moderna
FDA Reviews Moderna mRNA Flu Vaccine Ahead of Advisory Committee Meeting
FDA reviewers found no serious safety or efficacy concerns with Moderna’s mRNA influenza vaccine for adults 50 and over ahead of a key advisory panel meeting.
Moderna Aims for COVID-Flu Combination Vaccine for 2026-27 Season After FDA Decision Reversal
The pharmaceutical company said it would target the upcoming flu season for its next-generation combination vaccine following a positive regulatory development.